Provider Consolidation: Implications for Costs and Quality in Health Care Delivery

November 9, 2018: Health Policy and Bioethics Consortium
12:30 - 2 p.m.
Tosteson Medical Education Center, Room 227
260 Longwood Avenue

In the last decade, the traditional conception of individual physicians or medical groups has been increasingly replaced by consolidation under academic medical centers and other national or regional administrative organizations.  What are the implications of such organizational changes for patient care, and how has this trend contributed to overall rising health care costs?  How well are antitrust laws designed to ensure proper government oversight of mergers and the entities that result?


Leemore Dafny, PhD
Bruce V. Rauner Professor of Business Administration
Harvard Business School

Eric Gold, JD
Assistant Attorney General, Massachusetts
Chief, Health Care Division


Register here

This event is free and open to the public, but registration is required. Check back  

The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations. They are organized by the Center for Bioethics at Harvard Medical School and the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.